Compare · ROP vs TEM
ROP vs TEM
Side-by-side comparison of Roper Technologies Inc. (ROP) and Tempus AI Inc. (TEM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ROP and TEM operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- ROP is the larger of the two at $45.94B, about 3.7x TEM ($12.40B).
- TEM has been more active in the news (20 items in the past 4 weeks vs 13 for ROP).
- Both have 25 recent analyst ratings on file.
- Company
- Roper Technologies Inc.
- Tempus AI Inc.
- Price
- $413.44-0.50%
- $68.74+3.84%
- Market cap
- $45.94B
- $12.40B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NYSE
- NASDAQ
- IPO
- 1992
- 2024
- News (4w)
- 13
- 20
- Recent ratings
- 25
- 25
Roper Technologies Inc.
Roper Technologies, Inc. designs and develops software, and engineered products and solutions. The company offers management, campus solutions, laboratory information management, enterprise management, information solutions, transportation management, financial and compliance management, cloud-based financial analytics and performance management, and diagnostic and laboratory information system software; and software, services, and technologies for foodservice operations. It also provides cloud-based data, collaboration, and estimating automation software; electronic marketplace; visual effects and 3D content software; wireless sensor network and solutions; cloud-based software solutions; supply chain software; health care service and software; RFID card readers; data analytics and information; pharmacy software; and toll system and products, transaction and violation processing services, and intelligent traffic systems. In addition, the company offers precision rubber and polymer testing instruments, and data analysis software; ultrasound accessories; radiotherapy solutions; testing and analyzing plastic solutions; dispensers and metering pumps; control valves; precision weighing equipment; automated surgical scrub and linen dispensing equipment; water meters; optical and electromagnetic measurement systems; automated leak detection equipment; medical devices; products and services for water and gas utilities; and equipment and consumables. It also provides temperature control and emergency shutoff valves; turbomachinery control hardware, software, and services; specialized pumps; flow meter calibrators and controllers; vibration monitoring systems and controls; analytical instrument; drilling power section; pressure and level sensors; and non-destructive testing equipment. The company was formerly known as Roper Industries, Inc. and changed its name to Roper Technologies, Inc. in April 2015. The company was incorporated in 1981 and is based in Sarasota, Florida.
Latest ROP
- Aderant Launches Early Access to AI Agents Built to Enhance Law Firm Operations
- Illumia Adds PayPal and Venmo for College Tuition Payments
- iPipeline Introduces Novera API Hub, Creating a Connected Life, Annuity, and Wealth Ecosystem
- PayPal and Venmo Expand to Tuition Payments in New Integrations with Illumia, Nelnet Campus Commerce, and TouchNet
- Aderant Launches iTimekeep Integration with Harvey, Turning AI-Powered Legal Work into Billable Time
- SEC Form SCHEDULE 13G filed by Roper Technologies Inc.
- DAT: Contract van and reefer rates make record June-to-July gains
- Aderant and First AML Launch Integration to Automate Anti-Money Laundering Compliance for Law Firms
- SEC Form 8-K filed by Roper Technologies Inc.
- SEC Form SCHEDULE 13G filed by Roper Technologies Inc.
Latest TEM
- SEC Form 144 filed by Tempus AI Inc.
- CEO, Diagnostics Schoenherr Thomas Edward increased direct ownership by 3% to 87,021 units (SEC Form 4)
- CEO, Data Fukushima Ryan sold $1,000,020 worth of shares (14,286 units at $70.00) as part of a pre-agreed trading plan (SEC Form 4)
- Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs
- CEO, Diagnostics Schoenherr Thomas Edward sold $929,990 worth of shares (17,314 units at $53.71) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 89,715 units (SEC Form 4) (for withholding tax)
- CEO and Chairman Lefkofsky Eric P sold $6,577,840 worth of shares (132,591 units at $49.61), decreasing direct ownership by 6% to 2,098,130 units (SEC Form 4) (for tax liability)
- CEO, Data Fukushima Ryan sold $2,038,723 worth of shares (41,095 units at $49.61), decreasing direct ownership by 7% to 562,463 units (SEC Form 4) (withholding obligation)
- Chief Financial Officer Rogers James William sold $2,696,444 worth of shares (48,842 units at $55.21) as part of a pre-agreed trading plan, decreasing direct ownership by 32% to 106,024 units (SEC Form 4) (tax liability)
- EVP, Chief Legal Officer Polovin Andrew sold $1,542,674 worth of shares (30,075 units at $51.29) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 138,140 units (SEC Form 4) to satisfy tax liability
- Chief Accounting Officer Bartolucci Ryan M sold $306,342 worth of shares (6,175 units at $49.61), decreasing direct ownership by 8% to 67,866 units (SEC Form 4) (tax liability)